phosphatidylcholines has been researched along with amphotericin b in 306 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (amphotericin b) | Trials (amphotericin b) | Recent Studies (post-2010) (amphotericin b) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 17,210 | 673 | 4,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (16.01) | 18.7374 |
| 1990's | 71 (23.20) | 18.2507 |
| 2000's | 165 (53.92) | 29.6817 |
| 2010's | 17 (5.56) | 24.3611 |
| 2020's | 4 (1.31) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, MR | 1 |
| Kataoka, T; Koprowski, H | 1 |
| Nozawa, Y; Ohki, K; Ohnishi, SI | 1 |
| Bolard, J; Boudet, G | 1 |
| de Kruijff, B; van Hoogevest, P | 1 |
| Bittman, R | 1 |
| Archer, DB | 2 |
| Bunow, MR; Levin, IW | 1 |
| Asher, IM; Levin, IW | 1 |
| Bittman, R; Chen, WC | 1 |
| Klimov, AN; Nikiforova, AA; Tchistiakova, AM | 1 |
| Kauerz, MT; Op den Kamp, JA; van Deenen, LL | 1 |
| Gent, MP; Prestegard, JH | 1 |
| Ohnishi, S; Tanaka, KI | 1 |
| Abu-Salah, KM | 1 |
| Bolard, J; Carbon, C; Joly, V; Saint-Julien, L; Yeni, P | 1 |
| Benz, SK; Hartsel, SC; Peterson, RP; Whyte, BS | 2 |
| Adler-Moore, JP; Chiang, SM; Proffitt, RT; Satorius, A; Sullivan, L | 1 |
| Barber, KR; Davis, JH; Grant, CW; Hamilton, KS; Neil, K | 1 |
| Bolard, J; Cybulska, B; Heitz, F; Legrand, P | 1 |
| Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G | 1 |
| Bolard, J; Brajtburg, J; Jullien, S | 1 |
| Hartsel, SC; Peterson, RP; Whyte, BS | 1 |
| Cafiso, DS; Hartsel, SC; McGarvey, GJ; Perkins, WR | 1 |
| Cosgrove, RF; Green, AP; Liu, L; Payne, NI | 1 |
| Bienvenue, A; Maurin, L; Morin, P | 1 |
| Dupeyrat, M; Gary-Bobo, CM; Saint-Pierre-Chazalet, M; Thomas, C | 1 |
| Bolard, J; Gruda, I | 1 |
| Browning, I; Hynes, CA; Payne, NI | 1 |
| Prasad, R; Rao, TV; Trivedi, A | 1 |
| Bloch, K; Chin, J; Kawasaki, S; Ramgopal, M | 1 |
| Cohen, BE | 1 |
| Anderson, OR; Bittman, R; Chen, WC | 1 |
| de Kruijff, B; Demel, RA; Gerritsen, WJ; Oerlemans, A; van Deenen, LL | 1 |
| de Kruyff, B; Demel, RA; Geurts van Kessel, WS; Norman, AW; van Deenen, LL | 1 |
| Feingold, DS; HsuChen, CC | 2 |
| Demel, RA; Norman, AW; van Deenen, LL; van Zutphen, H | 1 |
| Sessa, G; Weissmann, G | 2 |
| Cass, A; Finkelstein, A | 1 |
| Laks, P; Oehlschlager, AC | 1 |
| Bogoslovskiĭ, NA; Feĭgin, AM; Flerov, MN; Gnanik, T; Pasechnik, VI | 1 |
| Aracava, Y; Schreier, S; Smith, IC | 1 |
| Aracava, Y; Deslauriers, R; Phadke, R; Schreier, S; Smith, IC | 1 |
| Bolard, J; Cheron, M; Mazerski, J | 1 |
| Bittman, R; Witzke, NM | 1 |
| Fainstein, V; Hersh, EM; Hopfer, RL; Juliano, R; Kasi, L; Lopez-Berestein, G; Luna, M; Mehta, K; Mehta, R; Mills, K | 1 |
| Bolard, J; Chabbert, M; Gary-Bobo, C; Vertut-Croquin, A | 1 |
| de Kruijff, B; Demel, RA; Teerlink, T | 1 |
| Belousova, II; Petrov, LN; Tereshin, IM; Virina, AM | 1 |
| Bittman, R; Readio, JD | 1 |
| Borowski, E; Cybulska, B; Gary-Bobo, CM; Prigent, Y | 1 |
| Chance, ML; Heath, S; New, RR | 1 |
| Inoue, K; Nojima, S; Oku, N | 1 |
| Bolard, J; Boudet, G; Seigneuret, M | 1 |
| Alekseev, SI; Ziskin, MC | 1 |
| Anachi, RB; Bansal, M; Easwaran, KR; Gaber, BP; Namboodri, K | 1 |
| Brajtburg, J; Elberg, S; Kobayashi, GS; Travis, SJ | 1 |
| Bolard, J; Brajtburg, J; Elberg, S; Kobayashi, GS | 1 |
| Lister, J | 1 |
| Barton, LL; Hutter, JJ; Patterson, TS; Shehab, ZM | 1 |
| Eng, RH; Fan-Havard, P; Gordon, DS; Graybill, JR; Gupta, R; Hausrath, SG; Johnson, ES; Kolokathis, A; Lee, LW; Meyer, RD; Mildvan, D; Patterson, TF; Pollard, RB; Pottage, JC; Sharkey, PK; Simberkoff, MS; Wolf, J | 1 |
| Davis, SS; Lance, MR; Washington, C | 1 |
| Anand, A; Anand, N | 1 |
| Brajtburg, J; Cohen, BE; Marquez, V; Ramos, H | 1 |
| Itkin, RJ; Johnson, LR; Krawiec, DR; Kurowsky, LK; Marks, CA; McKiernan, BC; Swenson, CE; Twardock, AR | 1 |
| Armstrong, D; Bernard, EM; Cicogna, CE; Ishimura, T; Sun, M; Tong, WP; White, MH | 1 |
| Wingard, JR | 1 |
| Mehta, J | 1 |
| Richardson, MD | 1 |
| Barwicz, J; Tancrède, P | 1 |
| Bhamra, R; Bolcsak, LE; Janoff, AS; Sa'ad, A; Swenson, CE | 1 |
| Chu, P; Evans, C; Hazel, D; Kelsey, S; Mehta, J; Newland, A; Powles, R; Riley, U; Singhal, S; Treleaven, J | 1 |
| Adkins, D; Brown, R; DiPersio, J; Goodnough, L; Khoury, H; Miller, G | 1 |
| Merhav, H; Mieles, L | 1 |
| Chanock, SJ; Figg, WD; Gupta, R; Hill, S; Jarosinski, P; Piscitelli, S; Pizzo, PA; Walsh, TJ; Whitcomb, P | 1 |
| Adedoyin, A; Anaissie, E; Bernardo, JF; Bolsack, LE; Boyle, A; Branch, RA; DeValeriola, D; DeWit, S; Horwith, G; Kelly, E; Klasterksy, J; Llanos-Cuentas, A; Lopez-Berestein, G; Sculier, JP; Swenson, CE | 1 |
| Evans, ME; Gubbins, PO; Rapp, RP | 1 |
| Arney, KL; Judson, MA; Tiernan, R | 1 |
| Gam, AA; Kenney, RT; Murray, HW; Sacks, DL; Sundar, S | 1 |
| Chan, CH; Cheng, AF; Chu, KC; Ho, AS; Koehler, AP; Lyon, DJ | 1 |
| Little, R; Walsh, TJ; Weng, DE; Wilson, WH | 1 |
| Guanci, R; Lilley, LL | 1 |
| Bae, SK; Choi, TB; Kim, JC; Kim, JD; Kim, JY; Lee, EO | 1 |
| Aronson, NE; Davis, C; Fraser, SL; Jackson, JD; Miller, RS; Oster, CN; Wortmann, GW | 1 |
| García Garmendia, JL; Garnacho-Montero, J; Jiménez Jiménez, F; Ortiz-Leyba, C | 1 |
| Kyi, AA; Myint, H; Winn, RM | 1 |
| Boyle, JA; Luke, RG | 1 |
| Kauffman, CA; Wiseman, SW | 1 |
| Anaissie, EJ; Bow, E; DiNubile, MJ; Hiemenz, JW; Horwith, G; Lee, L; Lister, J; Perfect, JR; Reboli, A; Seibel, NL; Silber, JL; Walsh, TJ | 1 |
| Hartsel, SC; Mikulecky, P; Ruckwardt, T; Scott, A; Scott, J | 1 |
| Bekersky, I; Boswell, GW; Buell, D | 1 |
| Chopra, R; Clark, AD; Franklin, IM; McKendrick, S; Tansey, PJ | 1 |
| Bellman, PC; Karter, DL; Kislak, JW; Lui, AY; Turett, GS | 1 |
| Hansen, M; Jacobsen, N; Jønsson, V; Ringdén, O; Tollemar, J | 1 |
| Johnson, JR; Kangas, PJ; West, M | 1 |
| Barenholz, Y; Frankenburg, S; Glick, D; Klaus, S | 1 |
| Cassidy, SM; Chou, JW; Holtorf, L; Kennedy, AL; Pritchard, PH; Ramaswamy, M; Wasan, KM | 1 |
| Goyal, AK; More, DK; Murray, HW; Singh, MK; Sundar, S | 1 |
| Boyle, JA; Swenson, CE | 1 |
| Cook, G; Franklin, IM | 1 |
| Hastings, JG; Mutimer, DJ; Singhal, S | 1 |
| Brown, JC; Cohen, MS; Kylstra, JA; Virata, SR; Wohl, DA | 1 |
| Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ | 1 |
| Hay, RJ | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Michels, B; Milhaud, J | 1 |
| Lee, L; Linden, P; Walsh, TJ | 1 |
| Kennedy, AL; Wasan, KM | 1 |
| Philips, DL; Sallah, S; Sallah, W; Semelka, RC; Vainright, JR | 1 |
| Rex, JH; Walsh, TJ | 1 |
| Fraser, SL; Rowles, DM | 1 |
| Martino, R; Sierra, J; Subirá, M; Sureda, A | 1 |
| Baddley, JW; Moser, SA; Pappas, PG; Sutton, DA | 1 |
| Schiller, GJ; Winston, DJ | 1 |
| Blowey, DL; Garg, UC; Kearns, GL; Warady, BA | 1 |
| Furebring, M; Oberg, G; Sjölin, J | 1 |
| Croft, SL; Yardley, V | 1 |
| Darling, K; Singh, J; Wilks, D | 1 |
| Fothergill, A; Ghannoum, M; Jessup, C; McCarthy, D; Messer, S; Pfaller, M; Reyes, G; Rinaldi, M | 1 |
| Leverger, G | 1 |
| Zager, RA | 1 |
| Blair, D; Guharoy, R; Khan, U; Medicis, J; Ramirez, L; Rolland, WA | 1 |
| Chan, KM; Linden, P; Williams, P | 1 |
| Ellis, RW; Fisher, NC; Hastings, JG; Jones, SG; Miller, SJ; Mutimer, DJ; Singhal, S | 1 |
| Denning, DW; Moore, CB; Morrissey, J; Warn, PA | 1 |
| Adedoyin, A; Bolcsak, LE; Branch, RA; Hellmann, A; Horwith, G; Janoff, AS; Radowska, D; Swenson, CE | 1 |
| Goyal, AK; Makharia, MK; Mandal, AK; Murray, HW; Singh, VP; Sundar, S | 1 |
| Grau, S; Isbert, F; Nolla-Salas, J; Riveiro, M; Sitges-Serra, A; Torrella, T; Torres-Rodríguez, JM | 1 |
| Allaouchiche, B; Chassard, D; Duflo, F | 1 |
| Böhnke, M; Frueh, BE; Goldblum, D; Zimmerli, S | 1 |
| Ali, LI; Carter, TH; Roy, V; Selby, GB | 1 |
| Lin, SJ; Schranz, J; Teutsch, SM | 1 |
| Farmaki, E; Graybill, JR; Roilides, E; Tollemar, J; Torres-Rodríguez, JM; Walsh, TJ | 1 |
| Adler-Shohet, F; Lieberman, JM; Waskin, H | 1 |
| Andrès, E; Herbrecht, R; Letscher-Bru, V; Tiphine, M | 1 |
| Kennedy, AL; Peteherych, KD; Ramaswamy, M; Wasan, KM | 1 |
| Andrès, E; Auvrignon, A; Eyer, D; Guillemain, R; Herbrecht, R; Letscher-Bru, V; Leverger, G; Pailler, C; Schaison, G; Suc, A | 1 |
| Garcia-Diaz, JB; Palau, L; Pankey, GA | 1 |
| Cook, PP | 1 |
| Caillot, D; Kara-Slimane, F; Mannone, L | 1 |
| Cortes, J; Estey, E; Fleming, RV; Husni, R; Kantarjian, HM; Lim, J; Pierce, S; Raad, I; Rolston, K | 1 |
| Ballesteros, MP; Frutos, P; Moreno, MA | 1 |
| Frothingham, R | 1 |
| Davis, RD; Drew, RH; Kanj, SS; McConnell, RR; Palmer, SM; Perfect, JR; Tapson, VF; Whitehouse, JD | 1 |
| Collazos, J; Ibarra, S; Martínez, E; Mayo, J | 1 |
| Knoppert, DC; Lee, DS; Salama, HE | 1 |
| Michels, B; Milhaud, J; Ponsinet, V; Takashi, M | 1 |
| Dupont, B | 1 |
| Cagnoni, PJ | 1 |
| Doxas, PG; Hajiioannou, JK; Kyrmizakis, DE; Papadakis, CE | 1 |
| Beyan, C; Cetin, T; Kaptan, K; Ural, AU; Yalçin, A | 1 |
| Altés, A; Briones, J; Brunet, S; Martino, R; Sierra, J; Subirà, M; Sureda, A | 1 |
| Campos, F; Candolfi, E; Herbrecht, R; Letscher-Bru, V; Randriamahazaka, R; Waller, J | 1 |
| Ballesteros, MP; Brime, B; Frutos, G; Frutos, P; Moreno, MA | 1 |
| Arikan, S | 1 |
| Bryant, RE; Hunter, AJ | 1 |
| Bizzotto, D; Shepherd, J; Stoodley, R; Wasan, KM | 1 |
| del Castillo, A; Martínez, S; Piñero, JE; Portús, M; Valladares, B | 1 |
| Brunson, ME; Duchini, A; McHutchison, JG; Pockros, PJ; Redfield, DC | 1 |
| Demir, M; Kaldir, M; Turgut, B; Vural, O | 1 |
| Georgopoulou, I; Gil-Lamaignere, C; Maloukou, A; Petrikkos, G; Roilides, E; Walsh, TJ | 1 |
| Fisher, M; Jozefczyk, K; Khakoo, R; Miller, K; Slain, D; Wierman, T | 1 |
| Brio, S; Cantón, E; Carrillo-Muñoz, AJ; del Valle, O; Guarro, J; Hernández-Molina, JM; Pemán, J; Quindós, G; Rodriguez, V; Ruesga, M; Santos, P | 1 |
| Dong, S; Han, X; Huang, W; Tang, J; Wang, E; Wang, J; Zhang, Z | 1 |
| Chaturon, K; Kraisintu, K; Rojanapanthu, P; Sarisuta, N | 1 |
| Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Egger, P; Gritsch, W; Joannidis, M; Kaneider, N; Wiedermann, CJ | 1 |
| Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
| Garnier, JM; Horelt, A; Minodier, P; Retornaz, K | 1 |
| Butani, L; Jain, A | 1 |
| Ritter, J | 1 |
| Cannon, JP; Danziger, LH; De Alba, F; Edward, DP; Fiscella, R; Garey, KW; Pattharachayakul, S; Piscitelli, S | 1 |
| Aoun, M; Gillard, PH; Hourez, R; Mariat, P | 1 |
| Buell, D; Calis, K; DeChristoforo, R; Donowitz, GR; Jarosinski, PF; Knudsen, TA; Nelson, LD; Roden, MM; Shiflett, SE; Starling, JM; Walsh, TJ | 1 |
| Altieri, S; Coppola, MG; Faella, F; Gradoni, L; Gramiccia, M; Pagliano, P; Rescigno, C; Rossi, M; Scalone, A | 1 |
| Haq, W; Khan, MA; Nasti, HT; Owais, M; Saima Dagger, K; Shehbaz, A; Syed, FM | 1 |
| Alvar, J; Clotet, B; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Prados, D; Ribera, E; Sirera, G; Sust, M; Torre-Cisneros, J; Videla, S | 1 |
| Celis, H; González-Damián, J; Ortega-Blake, I; Venegas, B | 1 |
| Barcena, R; Candela, A; de Vicente, E; Fortún, J; García, M; Honrubia, A; Martín-Davila, P; Moreno, S; Nuño, J; Pintado, V; Uriarte, M | 1 |
| Matsuoka, S; Murata, M | 1 |
| Segal, E; Sionov, E | 2 |
| Sims-McCallum, RP | 1 |
| Appel, M; Barratt, G; Bouvet, S; Gulik, A; Larabi, M; Pages, N; Pons, F; Schlatter, J | 1 |
| Anstead, GM; Cao, MK; Danaher, PJ; DeWitt, CC; Dolan, MJ | 1 |
| Gradoni, L; Gramiccia, M; Scalone, A | 1 |
| Mehta, H; Murray, HW; Rai, M; Singh, SP; Sundar, S; Suresh, AV | 1 |
| Alvar, J; Arribas, JR; Boix, V; Cañavate, C; Górgolas, M; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Márquez, M; Salas, A; Sust, M; Videla, S | 1 |
| Benjamin, DK; Dodds Ashley, E; Drew, RH; Duane Davis, R; Palmer, SM; Perfect, JR | 1 |
| Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P | 1 |
| Estany, C; Gómez, L; Martí, JM; Martino, R; Sierra, J; Subirà, M | 1 |
| Martino, R | 1 |
| Bartlett, K; Batty, DS; Choo, E; Marra, F; Risovic, V; Sivak, O; Wasan, KM | 1 |
| Brime, B; Frutos, G; Frutos, P; Molero, G | 1 |
| Collins, CD; Miller, AS; Pedersen, CA; Roux, RK; Schneider, PJ; Sierawski, SJ | 1 |
| Camacho, M; Gerbolés, E; Soler, M; Vila, L | 1 |
| Goldsmith, DR; Perry, CM | 1 |
| Byrd, RG; Cone, LA; Potts, BE; Wuesthoff, M | 1 |
| Alves, IC; Amato, VS; Floeter-Winter, LM; Kono, A; Maldonado, TP; Neto, VA; Rabello, A; Rotondo-Silva, A; Shikanai-Yasuda, MA | 1 |
| Aguado, JM; González-Vidal, D; Lumbreras, C | 1 |
| Carreira, EM; Clark, DD; Hussey, SL; Jeannerat, D; Martin, SE; Peter, M; Peterson, BR; Pretsch, E; Sohrmann, M; Stano, P; Vigassy, T; Walde, P; Zumbuehl, A | 1 |
| Murray, HW | 1 |
| French, SW; Tolentino, LF; Tsai, SF; Witt, MD | 1 |
| Auvrignon, A; Benoit, G; Demontoux, V; Fasola, S; Fratta, A; Le Guyader, N; Leverger, G; Pellegrino, B | 1 |
| Chu, A; Dominguez, EA; Gotz, V; Hooshmand-Rad, R; Morris, JA; Reed, MD; Weinberg, J | 1 |
| Lau, B; Patankar, N; Sivak, O; Wasan, KM | 1 |
| Perfect, JR | 2 |
| Edwards, JE; Fu, Y; Ibrahim, AS; Spellberg, B | 1 |
| Seibel, NL; Walsh, TJ; Wiley, JM | 1 |
| Alexander, D; Crompton, JA; Shihab, FS; Somerville, T | 1 |
| Pappas, PG | 1 |
| Hooshmand-Rad, R; Ito, JI | 1 |
| Chandrasekar, PH; Ito, JI | 1 |
| Baddour, LM; Ostrosky-Zeichner, L; Perfect, JR | 1 |
| Alexander, BD; Wingard, JR | 1 |
| Clemons, KV; Fernandez, B; Imai, J; Singh, G; Stevens, DA | 1 |
| Andes, D; Gauthier, GM; Nork, TM; Prince, R | 1 |
| Avorn, J; Fischer, MA; Rubin, RH; Winkelmayer, WC | 1 |
| Leather, H; Wingard, JR | 1 |
| Chandrasekar, PH; Hooshmand-Rad, R; Ito, JI | 1 |
| Barratt, G; Legrand, P | 1 |
| Looke, DF; Schlebusch, S | 1 |
| Adler-Shohet, FC; Groll, AH; Hempel, G; Lieberman, JM; Walsh, TJ; Würthwein, G | 1 |
| Akisu, M; Cetin, H; Hilmioglu, S; Kultursay, N; Metin, D; Yalaz, M | 1 |
| Armstrong, D; Lyman, CA; Petraitiene, R; Roilides, E; Stergiopoulou, T; Walsh, TJ | 1 |
| Hayes, D | 1 |
| Addison, RM; Alexander, BD; Alspaugh, JA; Chao, NJ; Dodds Ashley, ES; Perfect, JR | 1 |
| Bahna, P; Hachem, R; Hanna, H; Raad, I; Stephens, LC | 1 |
| Gabrielska, J; Gagoś, M; Gruszecki, WI; Gubernator, J | 1 |
| Saliba, F | 1 |
| Chandrasekar, P | 1 |
| Kleinberg, M | 1 |
| Drew, R | 1 |
| Cornila, C; Fohrer, C; Fornecker, L; Herbrecht, R; Marinescu, C; Nivoix, Y | 1 |
| Patankar, N; Wasan, KM | 1 |
| Adler-Moore, JP; Jensen, GM; Olson, JA; Proffitt, RT; Schwartz, J | 1 |
| Clemons, KV; Martinez, M; Parmar, R; Stevens, DA | 1 |
| Ikeuchi, H; Matsumori, N; Matsuoka, S; Murata, M; Umegawa, Y | 1 |
| Edwards, JE; Fu, Y; Ibrahim, AS; Rieg, G; Schwartz, J; Sheppard, DC; Spellberg, B | 1 |
| Olin, JL; Spooner, LM | 1 |
| Akard, LP; Dugan, MJ; Jansen, J; Leslie, JK; Mattison, R; Thompson, JM; Wack, MF | 1 |
| Adler-Moore, J; Avanesian, V; Edwards, JE; Fu, Y; Ibrahim, AS; Schwartz, J; Spellberg, B | 1 |
| Fohrer, C; Herbrecht, R; Nivoix, Y | 1 |
| Alfaro, RM; Armstrong, D; Bacher, J; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Walsh, TJ | 1 |
| Carey, ME; Corcoran, TE; Husain, S; Marcinkowski, AL; McCook, BM; McCurry, KR; Mihelc, KM; Ou, J; Paterson, DL; Pilewski, JM; Venkataramanan, R; Weber, L | 1 |
| Bartlett, K; Risovic, V; Rosland, M; Sivak, O; Wasan, KM | 1 |
| Bertrán-Pasarell, J; Fradera, J; González-Keelan, C; Guiot, HM; Méndez, W; Procop, GW; Sánchez-Sergentón, C; Tormos, LM | 1 |
| Amato Neto, V; Amato, VS; Bacha, HA; Campos, A; Nicodemo, AC; Shikanai-Yasuda, MA; Tuon, FF | 1 |
| Cheung, C; Feldmesser, M; Gialanella, P; Guo, Y | 1 |
| Forrest, GN; Mankes, K | 1 |
| Carreira, EM; Peter, M; Sohrmann, M; Stano, P; Walde, P; Zumbuehl, A | 1 |
| Harada, AS; Lau, W | 1 |
| Mert, A; Mete, B; Ozaras, R; Ozturk, R; Tabak, F; Yemisen, M | 1 |
| Gagoś, M; Gruszecki, WI; Hereć, M; Islamov, A; Kuklin, A | 1 |
| Frank, M; Jaradeh, SS; Ortega-Gutierrez, S; Szeder, V | 1 |
| Beltrame, A; Cerana, M; De Maria, A; Di Biagio, A; Pacini, D | 1 |
| Cappelli, B; Castagnola, E; Cuzzubbo, D; Faraci, M; Lanino, E; Moresco, L; Moroni, C | 1 |
| Bandettini, R; Di Marco, E; Mantero, E; Tamisani, AM; Tuo, P | 1 |
| Calza, L; Manfredi, R | 1 |
| Capilla, J; Clemons, KV; Sobel, RA; Stevens, DA | 1 |
| Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
| Altintas, ND; Arikan, S; Burnik, C; Cuenca-Estrella, M; Firat, P; Ozkaya, G; Selçuk, ZT; Serter, T; Topeli, A | 1 |
| Dockrell, DH; Metcalf, SC | 1 |
| Bellmann, R; Bellmann-Weiler, R; Joannidis, M; Weiler, S | 1 |
| Chamilos, G; Chemaly, R; Kontoyiannis, DP; Lewis, RE; Luna, M; Raad, II | 1 |
| Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Balagtas, J; Dvorak, CC; Gutierrez, K; Hong, DK; Sarwal, M; Sutherland, SM | 1 |
| Afif, C; Boktour, MR; Hachem, RY; Hanna, HA; Husni, RN; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Edwards, JE; Fu, Y; Gebremariam, T; Husseiny, MI; Ibrahim, AS; Spellberg, B; Stevens, DA | 1 |
| Gil-Lamaignere, C; Maloukou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Dalakiouridou, M; Dotis, J; Konstantinou, T; Panteliadis, C; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
| Beaman, K; Cohn, A; Odessey, E; Schechter, L | 1 |
| Adler-Moore, JP; Proffitt, RT | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lewis, RE | 1 |
| Konoki, K; Matsumori, N; Mouri, R; Murata, M; Oishi, T | 1 |
| Chiavacci, LA; Egito, ES; Formariz, TP; Franzini, CM; Oliveira, AG; Pestana, KC; Sarmento, VH; Scarpa, MV | 1 |
| Matsumori, N; Murata, M; Oishi, T; Umegawa, Y | 1 |
| Konoki, K; Matsumori, N; Murata, M; Takano, T | 1 |
| Asai, T; Oku, N; Osada, M; Shimizu, K; Takemoto, K; Yamamoto, Y | 1 |
| Huang, Z; Iman, M; Jaafari, MR; Szoka, FC | 1 |
| Barlow, DJ; Drake, AF; Foglia, F; Lawrence, MJ; Rogers, SE; Terry, AE | 1 |
| Matsumori, N; Murata, M; Nakagawa, Y; Oishi, T; Tahara, K; Tsuchikawa, H; Umegawa, Y | 1 |
| Efimova, SS; Ostroumova, OS; Schagina, LV | 1 |
| de Oliveira, AG; do Egito, ES; Franzini, CM; Molina, EF; Pestana, KC; Scarpa, MV | 1 |
| Brandis, KA; Dudley-Rucker, N; Gale, S; Goldberg, A; Jiang, H; Jinn, S; Langmade, SJ; Ory, DS; Ren, A; Schaffer, JE; Sidhu, R | 1 |
| Barlow, DJ; Clifton, LA; Foglia, F; Fragneto, G; Lawrence, MJ | 1 |
| Chen, X; Gao, Z; Hu, J; Ma, N; Sun, Y; Zhang, L; Zhao, M | 1 |
| Akeroyd, FA; Barlow, DJ; Foglia, F; Gascoyne, KF; Lawrence, MJ; Rogers, SE; Webster, JR | 1 |
| Ahmad, A; Cheng, L; Ke, L; Ullah, S; Wang, A; Yuan, Q | 1 |
| Ortega-Blake, I; Parmananda, P; Récamier, KS | 1 |
| Bykov, EE; Efimova, SS; Olsufyeva, EN; Ostroumova, OS; Tevyashova, AN | 1 |
| Carrer, DC; Moody, D; Peralta, MF; Smith, H; Tristram-Nagle, S | 1 |
| Barzycka, A; Czub, J; Grela, E; Grudzinski, W; Gruszecki, WI; Luchowski, R; Nowak, K; Tarkowski, P; Wieczór, M; Zielinska, J | 1 |
| Jiang, W; Mudalige, T; Van Haute, D | 1 |
| Galigama, RD; Garg, P; Mallela, LS; Roy, G; Roy, S; Thorat, VS; Venuganti, VVK | 1 |
| Bailey-Hytholt, CM; Nie, B; Shen, TL; Shukla, A; Tripathi, A | 1 |
| Donaghey, R; Giacobbo, V; Khadke, S; Perrie, Y; Roces, CB; Su, Y | 1 |
| Feng, S; Wang, J; Zhu, H | 1 |
| Alonso, A; Alonso, L; Kipnis, A; Pimenta, LKL | 1 |
32 review(s) available for phosphatidylcholines and amphotericin b
| Article | Year |
|---|---|
Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?
Topics: Amphotericin B; Antifungal Agents; Cholesterol Esters; Drug Combinations; Humans; Molecular Structure; Phosphatidylcholines; Phosphatidylglycerols; Structure-Activity Relationship | 1997 |
Lipid complexes of amphotericin B: the competitive picture.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol Esters; Drug Combinations; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Amphotericin B lipid complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Successful medical management of isolated renal zygomycosis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Kidney Diseases; Male; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Radiography; Rhizopus; Tomography Scanners, X-Ray Computed | 1998 |
AmBisome (liposomal amphotericin B): a comparative review.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Lipid amphotericin B combinations; 'la crème de la crème'?
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Combinations; Europe; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Aspergillosis case-fatality rate: systematic review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Case-Control Studies; Central Nervous System Fungal Infections; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Drug Combinations; Female; Humans; Male; MEDLINE; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Prognosis | 2001 |
Antifungal compounds: controversies, queries and conclusions.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemoprevention; Drug Combinations; Humans; Mice; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
[New lipid formulations of amphotericin B. Review of the literature].
Topics: Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Chemistry, Pharmaceutical; Drug Combinations; Fat Emulsions, Intravenous; Humans; Liposomes; Neutropenia; Patient Selection; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2001 |
[Invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Drug Combinations; Humans; Immunosuppression Therapy; Itraconazole; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Prognosis; Radiography, Thoracic; Risk Factors; Tomography, X-Ray Computed | 2001 |
Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Lung Diseases; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2001 |
Overview of the lipid formulations of amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Drug Combinations; Humans; Liposomes; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Liposomes; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Combinations; Female; Humans; Inguinal Canal; Itraconazole; Liver Transplantation; Lung; Lung Diseases, Fungal; Lymphatic Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Survival Rate | 2002 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2003 |
[Amphotericin B and its lipid formulations].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Amphotericin B lipid complex: in visceral leishmaniasis.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Drug Combinations; Half-Life; Humans; Leishmaniasis, Visceral; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Comparison of the efficacy and pharmacology of formulations of amphotericin B used in treatment of leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drug Combinations; Humans; Leishmaniasis; Liposomes; Multicenter Studies as Topic; Phosphatidylcholines; Phosphatidylglycerols | 2005 |
What is the current and future status of conventional amphotericin B?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Colloids; Deoxycholic Acid; Drug Combinations; Humans; Liposomes; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2006 |
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
Topics: Aerosols; Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2006 |
Antifungal combination treatment: a future perspective.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Echinocandins; Forecasting; Humans; In Vitro Techniques; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus; Drug Combinations; Humans; Lung; Male; Phosphatidylcholines; Phosphatidylglycerols; Pneumonia; Respiratory Distress Syndrome | 2007 |
Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Combinations; Humans; Immunocompromised Host; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2007 |
Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation.
Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Arthritis, Rheumatoid; Diabetes Complications; Drug Combinations; Humans; Infliximab; Male; Maxillary Sinus; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols | 2008 |
Amphotericin B lipid preparations: what are the differences?
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2008 |
Immunocompromised hosts: immunopharmacology of modern antifungals.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Azoles; beta-Glucans; Cytokines; Drug Combinations; Echinocandins; Humans; Immunity; Immunocompromised Host; Leukocytes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2008 |
27 trial(s) available for phosphatidylcholines and amphotericin b
| Article | Year |
|---|---|
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cohort Studies; Drug Combinations; Female; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 1996 |
Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Dog Diseases; Dogs; Drug Carriers; Drug Combinations; Female; Glomerular Filtration Rate; Kidney; Liposomes; Male; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome | 1996 |
Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Liver Diseases; Male; Phosphatidylcholines; Phosphatidylglycerols; Splenic Diseases | 1997 |
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Kidney Diseases; Leishmaniasis, Mucocutaneous; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Reference Values | 1997 |
An open, non-comparative evaluation of the efficacy and safety of amphotericin B lipid complex as treatment of neutropenic patients with presumed or confirmed pulmonary fungal infections.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Humans; Hypokalemia; Lung; Lung Diseases, Fungal; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1998 |
Renal effects of amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Drug Combinations; Female; Humans; Kidney; Male; Meningitis, Cryptococcal; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Cryptococcosis; Drug Combinations; Female; Humans; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.
Topics: Adolescent; Adult; Amphotericin B; Analysis of Variance; Antimony; Antiprotozoal Agents; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Single-Blind Method | 1998 |
Adverse drug reactions associated with the administration of amphotericin B lipid complex (Abelcet)
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Combinations; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 1999 |
Side-effects of amphotericin B lipid complex (Abelcet) in the Scandinavian population.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Bilirubin; Bone Marrow Transplantation; Creatinine; Drug Combinations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Scandinavian and Nordic Countries | 2000 |
A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Antimony; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols; Probability; Treatment Outcome | 1999 |
Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Humans; Leukemia; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2001 |
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Treatment Outcome | 2003 |
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Costs; Female; Hospital Costs; Humans; India; Infant; Leishmaniasis, Visceral; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
Topics: Adolescent; Adult; Aerosols; Aged; Amphotericin B; Deoxycholic Acid; Double-Blind Method; Drug Combinations; Female; Heart-Lung Transplantation; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Racial Groups; Retrospective Studies | 2004 |
Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Drug Combinations; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Hypokalemia; Immunocompromised Host; Incidence; Kidney Diseases; Male; Middle Aged; Mycoses; Neutropenia; Peripheral Blood Stem Cell Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Incidence; Infant; Kidney Diseases; Leishmaniasis, Visceral; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Population pharmacokinetics of amphotericin B lipid complex in neonates.
Topics: Amphotericin B; Anti-Infective Agents; Candida; Candidiasis; Drug Combinations; Humans; Infant, Newborn; Models, Biological; Phosphatidylcholines; Phosphatidylglycerols | 2005 |
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aerosols; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Safety; Transplantation, Homologous; Treatment Outcome | 2006 |
Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Child; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Postoperative Complications; Prednisone; Stem Cell Transplantation; Steroids; Time Factors; Treatment Outcome | 2006 |
Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B.
Topics: Aged; Amphotericin B; Antiprotozoal Agents; Drug Combinations; Female; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects | 2007 |
Penetration of amphotericin B lipid formulations into pleural effusion.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Critical Illness; Drug Combinations; Female; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Pleural Effusion | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
247 other study(ies) available for phosphatidylcholines and amphotericin b
| Article | Year |
|---|---|
Fusion of liposomes containing conductance probes with black lipid films.
Topics: Amphotericin B; Binding Sites; Cholesterol; Gramicidin; Liposomes; Membranes, Artificial; Models, Biological; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines | 1976 |
Lipids and cell fusion in vitro: effect of amphotericin B.
Topics: Amphotericin B; Animals; Cell Fusion; Cell Membrane; Cholesterol; Clone Cells; Hemagglutination, Viral; Lysophosphatidylcholines; Membranes; Mice; Parainfluenza Virus 1, Human; Phosphatidylcholines; Viral Proteins | 1975 |
Interaction of polyene antibiotics with sterols in phosphatidylcholine bilayer membranes as studied by spin probes.
Topics: Amphotericin B; Electron Spin Resonance Spectroscopy; Filipin; Kinetics; Membranes, Artificial; Molecular Conformation; Phosphatidylcholines; Polyenes; Spin Labels; Sterols | 1979 |
Interaction of the polyene antibiotic amphotericin B with phospholipid bilayer membranes: a circular dichroism study.
Topics: Amphotericin B; Circular Dichroism; Membranes, Artificial; Micelles; Molecular Conformation; Phosphatidylcholines | 1979 |
Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes.
Topics: Amphotericin B; Binding Sites; Cholesterol; Eggs; Fatty Acids, Unsaturated; Ion Channels; Liposomes; Models, Biological; Permeability; Phosphatidylcholines; Potassium | 1978 |
Sterol-polyene antibiotic complexation: probe of membrane structure.
Topics: Amphotericin B; Cholesterol; Filipin; Kinetics; Membranes; Mycoplasma; Phosphatidylcholines; Polyenes | 1978 |
Effect of the lipid composition of Mycoplasma mycoides subspecies capri and phosphatidylcholine vesicles upon the action of polyene antibiotics.
Topics: Amphotericin B; Biological Transport; Cholesterol; Egg Yolk; Female; Filipin; Kinetics; Lipid Metabolism; Models, Biological; Mycoplasma mycoides; Phosphatidylcholines; Polyenes; Potassium | 1976 |
Vibrational Raman spectra of lipid systems containing amphotericin B.
Topics: Amphotericin B; Electric Conductivity; Membranes, Artificial; Models, Biological; Molecular Conformation; Phosphatidylcholines; Spectrum Analysis, Raman; Temperature | 1977 |
Effects of temperature and molecular interactions on the vibrational infrared spectra of phospholipid vesicles.
Topics: Amphotericin B; Binding Sites; Cholesterol; Membranes, Artificial; Models, Biological; Phosphatidylcholines; Spectrophotometry, Infrared; Temperature; Water | 1977 |
Kinetics of association of amphotericin B with vesicles.
Topics: Amphotericin B; Chemical Phenomena; Chemistry; Cholesterol; Kinetics; Phosphatidylcholines; Structure-Activity Relationship | 1977 |
The use of a fluorescent sterol to investigate the mode of action of amphotericin methyl ester, a polyene antibiotic.
Topics: Amphotericin B; Ergosterol; Fluorescent Dyes; Mycoplasma mycoides; Phosphatidylcholines; Sonication; Spectrometry, Fluorescence | 1975 |
Inhibition of cholesterol esterification by polyene antibiotics in blood plasma.
Topics: Acyltransferases; Amphotericin B; Antifungal Agents; Carbon Radioisotopes; Cholesterol; Humans; Lipoproteins; Phosphatidylcholines; Polyenes | 1975 |
Action of pancreatic phospholipase A2 on phosphatidylcholine bilayers in different physical states.
Topics: Amphotericin B; Calorimetry; Cholesterol; Fatty Acids; Filipin; Liposomes; Membranes, Artificial; Phosphatidylcholines; Phospholipases; Temperature | 1975 |
Interaction of the polyene antibiotics with lipid bilayer vesicles containing cholesterol.
Topics: Amphotericin B; Binding Sites; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gel; Filipin; Magnetic Resonance Spectroscopy; Membranes, Artificial; Models, Biological; Molecular Conformation; Nystatin; Phosphatidylcholines; Polyenes; Spectrophotometry, Ultraviolet | 1976 |
Heterogeneity in the fluidity of intact erythrocyte membrane and its homogenization upon hemolysis.
Topics: Amphotericin B; Binding Sites; Cell Membrane; Cholesterol; Erythrocytes; Hemolysis; Humans; Molecular Conformation; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Phosphatidylserines; Saponins; Spin Labels; Structure-Activity Relationship; Temperature | 1976 |
Alteration of the permeability of the human erythrocyte membrane to cations by liposome-incorporated amphotericin B.
Topics: Amphotericin B; Cell Membrane Permeability; Cholesterol; Erythrocyte Membrane; Humans; In Vitro Techniques; Liposomes; Particle Size; Phosphatidylcholines; Potassium; Sodium | 1992 |
Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Circular Dichroism; Dimyristoylphosphatidylcholine; Drug Carriers; Kidney; Kidney Tubules; Male; Membranes, Artificial; Phosphatidylcholines; Phospholipids; Rabbits | 1992 |
Potassium-selective amphotericin B channels are predominant in vesicles regardless of sidedness.
Topics: Amphotericin B; Chlorides; Hydrogen-Ion Concentration; Ion Channels; Kinetics; Liposomes; Membranes; Models, Biological; Models, Molecular; Molecular Conformation; Permeability; Phosphatidylcholines; Potassium | 1991 |
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents.
Topics: Amphotericin B; Animals; Cholesterol; Drug Carriers; Female; Freeze Drying; Lethal Dose 50; Liposomes; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Rats; Rats, Inbred Strains | 1991 |
Phase behaviour of amphotericin B multilamellar vesicles.
Topics: Amphotericin B; Calorimetry, Differential Scanning; Dimyristoylphosphatidylcholine; Drug Carriers; Electron Spin Resonance Spectroscopy; Freeze Etching; Liposomes; Microscopy, Electron; Molecular Structure; Phosphatidylcholines; Phosphatidylglycerols; Thermodynamics | 1991 |
A kinetic method for measuring functional delivery of amphotericin B by drug delivery systems.
Topics: Amphotericin B; Arylsulfonates; Cholesterol; Drug Carriers; Ergosterol; Hydrogen-Ion Concentration; Kinetics; Liposomes; Phosphatidylcholines | 1991 |
One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium.
Topics: Absorption; Amphotericin B; Buffers; Cell Membrane Permeability; Cholesterol; Circular Dichroism; Electrochemistry; Ergosterol; Erythrocyte Membrane; Humans; Liposomes; Nystatin; Phosphatidylcholines; Potassium; Saccharomyces cerevisiae; Water | 1991 |
Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles.
Topics: Amphotericin B; Candida albicans; Cryptococcus neoformans; Egg Yolk; Erythrocytes; Glycocholic Acid; Humans; In Vitro Techniques; Micelles; Phosphatidylcholines | 1990 |
Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.
Topics: Amphotericin B; Candida albicans; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Liposomes; Male; Phosphatidylcholines; Potassium | 1990 |
Amphotericin B and Nystatin show different activities on sterol-free vesicles.
Topics: Amphotericin B; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Hydrogen-Ion Concentration; Kinetics; Liposomes; Models, Biological; Nystatin; Permeability; Phosphatidylcholines; Potassium | 1989 |
A selective cholesterol-dependent induction of H+/OH- currents in phospholipid vesicles by amphotericin B.
Topics: Amphotericin B; Cholesterol; Hydroxides; Liposomes; Models, Biological; Phosphatidylcholines; Protons | 1988 |
In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice.
Topics: Amphotericin B; Animals; Ergosterol; Lethal Dose 50; Liposomes; Male; Mice; Particle Size; Phosphatidylcholines; Tissue Distribution | 1987 |
A new paramagnetic analogue of cholesterol as a tool for studying molecular interactions of genuine cholesterol.
Topics: Amphotericin B; Cholesterol; Electron Spin Resonance Spectroscopy; Filipin; Models, Biological; Molecular Conformation; Phosphatidylcholines; Spectrometry, Fluorescence | 1987 |
Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: a monolayer study.
Topics: Amphotericin B; Chemical Phenomena; Chemistry, Physical; Cholesterol; Macromolecular Substances; Phosphatidylcholines; Sterols; Structure-Activity Relationship; Surface Properties | 1988 |
On the existence of an amphotericin B--sterol complex in lipid vesicles and in propanol-water systems.
Topics: 1-Propanol; Amphotericin B; Cholesterol; Circular Dichroism; Ergosterol; Liposomes; Models, Biological; Molecular Conformation; Phosphatidylcholines; Water | 1987 |
Characterization of proliposomes.
Topics: Amphotericin B; Chemistry, Pharmaceutical; Liposomes; Microscopy, Electron; Particle Size; Phosphatidylcholines; Temperature | 1986 |
Phospholipid enrichment of Saccharomyces cerevisiae and its effect on polyene sensitivity.
Topics: Amino Acids; Amphotericin B; Antifungal Agents; Biological Transport; Filipin; Nystatin; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phospholipids; Saccharomyces cerevisiae | 1985 |
Sterol control of the phosphatidylethanolamine-phosphatidylcholine conversion in the yeast mutant GL7.
Topics: Adenosine Triphosphate; Amphotericin B; Cell Membrane; Cholesterol; Ergosterol; Filipin; Methylation; Methyltransferases; Mutation; Phosphatidylcholines; Phosphatidylethanolamine N-Methyltransferase; Phosphatidylethanolamines; Phosphorylation; S-Adenosylmethionine; Saccharomyces cerevisiae | 1985 |
Concentration- and time-dependence of amphotericin-B induced permeability changes across ergosterol-containing liposomes.
Topics: Amphotericin B; Egg Yolk; Ergosterol; Kinetics; Liposomes; Models, Biological; Permeability; Phosphatidylcholines | 1986 |
Interaction of filipin 3 and amphotericin B with lecithin-sterol vesicles and cellular membranes. Spectral and electron microscope studies.
Topics: Alcohols; Amphotericin B; Androstanes; Animals; Chemical Phenomena; Chemistry; Cholesterol; Cilia; Circular Dichroism; Ergosterol; Fatty Acids, Unsaturated; Lactones; Membranes; Microscopy, Electron; Phosphatidylcholines; Polycyclic Compounds; Polyenes; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet; Sterols; Surface Properties; Suspensions; Terpenes; Tetrahymena pyriformis; Ultrasonics | 1974 |
Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. Specificity of the membrane permeability changes induced by the polyene antibiotics.
Topics: Acholeplasma laidlawii; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cell Membrane; Cell Membrane Permeability; Cholesterol; Fatty Acids, Unsaturated; Glucose; Glucosephosphate Dehydrogenase; Kinetics; Lactones; Liposomes; Natamycin; Nystatin; Phosphatidylcholines; Polyenes; Potassium; Receptors, Drug; Spectrophotometry, Ultraviolet; Sterols; Streptomyces; Time Factors | 1974 |
Studies on the biological properties of polyene antibiotics: comparison of other polyenes with filipin in their ability to interact specifically with sterol.
Topics: Acetates; Acholeplasma laidlawii; Alkenes; Amino Sugars; Amphotericin B; Androstanes; Antifungal Agents; Calorimetry; Cell Membrane; Cholestanol; Cholestenes; Cholesterol; Erythrocytes; Fatty Acids, Unsaturated; Fatty Alcohols; Glycosides; Humans; Ketosteroids; Lactones; Liposomes; Membranes; Natamycin; Nystatin; Phosphatidylcholines; Spectrophotometry, Ultraviolet; Sterols; Structure-Activity Relationship | 1972 |
Polyene antibiotic action on lecithin liposomes: effect of cholesterol and fatty acyl chains.
Topics: Alkenes; Amphotericin B; Antifungal Agents; Cell Membrane Permeability; Cholesterol; Chromatography, Thin Layer; Digitonin; Fatty Acids; Fungi; Liposomes; Models, Biological; Phosphatidylcholines | 1973 |
Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes).
Topics: Amphotericin B; Anti-Bacterial Agents; Digitonin; Glucose; Liposomes; Models, Biological; Nystatin; Permeability; Phosphatidylcholines; Phospholipids; Sterols; Structure-Activity Relationship | 1973 |
The action of polyene antibiotics on lipid bilayer membranes in the presence of several cations and anions.
Topics: Amphotericin B; Antifungal Agents; Barium; Calcium Chloride; Chemical Phenomena; Chemistry; Chemistry, Physical; Chlorides; Cholesterol; Drug Stability; Electric Conductivity; Fatty Acids; Lactones; Lanthanum; Magnesium; Membrane Potentials; Membranes, Artificial; Natamycin; Nitrates; Nystatin; Oleic Acids; Phosphates; Phosphatidylcholines; Sodium Chloride; Sulfates | 1971 |
Incorporation of lysozyme into liposomes. A model for structure-linked latency.
Topics: Amines; Amphotericin B; Cell Wall; Cholesterol; Chromatography, Gel; Glucose; Micrococcus; Muramidase; Nystatin; Ovalbumin; Phosphatidylcholines; Phospholipids; Stearic Acids; Surface-Active Agents | 1970 |
Permeability and electrical properties of thin lipid membranes.
Topics: Amphotericin B; Cell Membrane Permeability; Cholesterol; Diffusion; Electric Conductivity; Electricity; Iodides; Iodine; Ions; Lipids; Membranes, Artificial; Nystatin; Osmosis; Phosphatidylcholines; Surface Properties; Temperature; Viscosity; Water-Electrolyte Balance | 1968 |
Effect of polyene antibiotics of phospholipid spherules containing varying amounts of charged components.
Topics: Amphotericin B; Anti-Bacterial Agents; Cholesterol; Electrochemistry; Membranes, Artificial; Nystatin; Phosphatidylcholines; Phospholipids | 1967 |
Nitroxide spin-probe study of amphotericin B-ergosterol interaction in egg phosphatidylcholine multilayers.
Topics: Amphotericin B; Cyclic N-Oxides; Egg Yolk; Electron Spin Resonance Spectroscopy; Ergosterol; Female; Liposomes; Magnetic Resonance Spectroscopy; Molecular Conformation; Nystatin; Phosphatidylcholines; Spin Labels | 1980 |
[Role of sterols in the interaction of polyene antibiotics with lipid membranes].
Topics: Amphotericin B; Anti-Bacterial Agents; Elasticity; In Vitro Techniques; Ion Channels; Lipid Bilayers; Membrane Lipids; Phosphatidylcholines; Polyenes; Sterols; Structure-Activity Relationship | 1981 |
Effect of amphotericin B on membranes: a spin probe study.
Topics: Amphotericin B; Cholesterol; Electron Spin Resonance Spectroscopy; Membranes, Artificial; Phosphatidylcholines; Pulmonary Surfactants | 1981 |
Effects of amphotericin B on membrane permeability--kinetics of spin probe reduction.
Topics: Amphotericin B; Cell Membrane Permeability; Cholesterol; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Kinetics; Lipid Bilayers; Phosphatidylcholines; Surface Properties | 1981 |
Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and nonaromatic heptaene antibiotics (vacidin A and amphotericin B).
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candicidin; Circular Dichroism; Liposomes; Molecular Conformation; Phosphatidic Acids; Phosphatidylcholines; Spectrophotometry | 1984 |
Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphatidylcholine/sterol vesicles.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candicidin; Chemical Phenomena; Chemistry; Cholesterol; Ergosterol; Kinetics; Liposomes; Phosphatidylcholines; Polyenes; Sterols | 1984 |
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
Topics: Amphotericin B; Animals; Candidiasis; Dimyristoylphosphatidylcholine; Liposomes; Mice; Phosphatidylcholines; Phosphatidylglycerols | 1983 |
Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study.
Topics: Amphotericin B; Cholesterol; Circular Dichroism; Ergosterol; Liposomes; Molecular Conformation; Permeability; Phosphatidylcholines; Structure-Activity Relationship | 1983 |
The action of pimaricin, etruscomycin and amphotericin B on liposomes with varying sterol content.
Topics: Amphotericin B; Antifungal Agents; Cholesterol; Ergosterol; Kinetics; Liposomes; Lucensomycin; Natamycin; Phosphatidylcholines; Potassium; Protein Binding; Structure-Activity Relationship | 1980 |
[Circular dichroism study of amphotericin B interaction with the sterols of Candida albicans strains sensitive and resistant to polyene antibiotics].
Topics: Amphotericin B; Candida albicans; Circular Dichroism; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Microbial; Liposomes; Phosphatidylcholines; Sterols; Time Factors | 1982 |
Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols.
Topics: Amphotericin B; Borates; Kinetics; Liposomes; Phosphatidylcholines; Sterols; Structure-Activity Relationship | 1982 |
Cation permeability induced by two aromatic heptaenes, vacidin A and candicidin D on phospholipid unilamellar vesicles.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candicidin; Cations; Cholesterol; Egg Yolk; Ergosterol; Female; Membranes, Artificial; Nystatin; Permeability; Phosphatidylcholines; Time Factors | 1981 |
Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes.
Topics: Amphotericin B; Animals; Antifungal Agents; Leishmaniasis, Visceral; Liposomes; Liver; Mice; Mice, Inbred Strains; Phosphatidylcholines | 1981 |
Selective release of non-electrolytes from liposomes upon perturbation of bilayers by temperature change or polyene antibiotics.
Topics: Amphotericin B; Anions; Anti-Bacterial Agents; Dextrans; Digitonin; Filipin; Glucose; Kinetics; Lipid Bilayers; Liposomes; Nystatin; Permeability; Phosphatidylcholines; Polyenes; Temperature | 1980 |
Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence.
Topics: Amphotericin B; Cholesterol; Circular Dichroism; Dose-Response Relationship, Drug; Lipid Bilayers; Membrane Fluidity; Phosphatidylcholines; Spectrum Analysis | 1980 |
Millimeter microwave effect on ion transport across lipid bilayer membranes.
Topics: Amphotericin B; Cholesterol; Electric Conductivity; Gramicidin; Hot Temperature; Ion Channels; Ion Transport; Lipid Bilayers; Membrane Lipids; Membrane Potentials; Microwaves; Phosphatidylcholines; Tetraphenylborate | 1995 |
Molecular modeling studies on amphotericin B and its complex with phospholipid.
Topics: Amphotericin B; Computer Simulation; Models, Molecular; Molecular Structure; Phosphatidylcholines; Software | 1995 |
Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
Topics: Amphotericin B; Animals; Bile Acids and Salts; Candidiasis; Cryptococcosis; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred Strains; Micelles; Phosphatidylcholines | 1994 |
Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.
Topics: Amphotericin B; Animals; Bile Acids and Salts; Cells, Cultured; Circular Dichroism; Drug Carriers; Drug Stability; Erythrocytes; Fibroblasts; Humans; Lipoproteins; Mice; Micelles; Mycoses; Phosphatidylcholines; Potassium; Spectrophotometry; Therapeutic Equivalency | 1994 |
Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience.
Topics: Amphotericin B; Animals; Antifungal Agents; Dogs; Drug Combinations; Mice; Mycoses; North America; Phosphatidylcholines; Phosphatidylglycerols; Rats | 1996 |
Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Dermatomycoses; Drug Combinations; Drug Resistance, Microbial; Female; Fusarium; Humans; Immunocompromised Host; Mycoses; Neutropenia; Paranasal Sinus Diseases; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Evidence for the formation of amphotericin B-phospholipid complexes in Langmuir monolayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Antifungal Agents; Dimyristoylphosphatidylcholine; Drug Carriers; Emulsions; Membranes, Artificial; Phosphatidylcholines; Surface Properties | 1996 |
Rhinocerebral mucormycosis: cure without surgery?
Topics: Amphotericin B; Antifungal Agents; Brain Diseases; Drug Combinations; Humans; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Sinusitis | 1996 |
Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
Topics: Amphotericin B; Animals; Antifungal Agents; Bile Acids and Salts; Deoxycholic Acid; Drug Carriers; Glycocholic Acid; Leishmania mexicana; Liposomes; Micelles; Ovum; Phosphatidylcholines | 1995 |
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.
Topics: Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Combinations; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 1997 |
Criteria for use of amphotericin B lipid complex injections in adults and children.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Drug Combinations; Humans; Injections, Intravenous; Kidney Function Tests; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1996 |
The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers.
Topics: Adsorption; Amphotericin B; Cholesterol; Ergosterol; Membranes, Artificial; Micelles; Phosphatidylcholines; Surface Properties | 1997 |
Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol; Chromatography, High Pressure Liquid; Deoxycholic Acid; Drug Combinations; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 1997 |
[Amphotericin B--lipid complex].
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Combinations; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Transplantation, Autologous; Transplantation, Homologous | 1997 |
Resolution of invasive central nervous system aspergillosis in a transplant recipient.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Encephalitis; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphatidylcholines; Phosphatidylglycerols; Prognosis | 1997 |
Amphotericin B lipid complex in the treatment of invasive fungal infections in liver transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Monitoring; Female; Humans; Liver Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Transplantation, Homologous | 1997 |
Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fusarium; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Soil Microbiology | 1997 |
Splenic cytokine responses in Indian kala-azar before and after treatment.
Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Cytokines; Drug Combinations; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmaniasis, Visceral; Phosphatidylcholines; Phosphatidylglycerols; Spleen | 1998 |
Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex.
Topics: Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Drug Combinations; Humans; Male; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1998 |
Communication averts an overdose.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Communication; Drug Combinations; Drug Overdose; Drug Prescriptions; Humans; Male; Medication Errors; Middle Aged; Personnel, Hospital; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chemical Precipitation; Circular Dichroism; Drug Carriers; Drug Stability; Erythrocytes; Hemolysis; Humans; Liposomes; Microbial Sensitivity Tests; Microscopy, Electron; Particle Size; Phosphatidylcholines; Temperature | 1997 |
Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis.
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Humans; Leishmaniasis, Cutaneous; Male; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Respiration Disorders | 1998 |
Anaphylaxis upon switching lipid-containing amphotericin B formulations.
Topics: Adult; Amphotericin B; Anaphylaxis; Antifungal Agents; Coccidioidomycosis; Drug Combinations; Humans; Injections, Intravenous; Injections, Intraventricular; Lipids; Male; Meningitis, Fungal; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Lipid and stress dependence of amphotericin B ion selective channels in sterol-free membranes.
Topics: Amphotericin B; Arylsulfonates; Eicosanoic Acids; Electric Conductivity; Fluorescent Dyes; Ion Channels; Lipid Metabolism; Liposomes; Osmotic Pressure; Phosphatidylcholines | 1998 |
A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology.
Topics: Adult; Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Female; Hematologic Neoplasms; Humans; Immune Tolerance; Leukocyte Count; Male; Mycoses; Neutrophils; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Treatment Outcome; Water-Electrolyte Imbalance | 1998 |
Amphotericin B lipid complex therapy in an AIDS patient with Rhodotorula rubra fungemia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Combinations; Fungemia; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Rhodotorula | 1998 |
Severe and common side-effects of amphotericin B lipid complex (Abelcet)
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Hematologic Diseases; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Serious adverse event after unrecognized substitution of one amphotericin B lipid preparation for another.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Carriers; Drug Combinations; Drug Compounding; Humans; Kidney Transplantation; Male; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.
Topics: Administration, Topical; Amphotericin B; Animals; Antiprotozoal Agents; Cholesterol Esters; Drug Combinations; Ethanol; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred CBA; Micelles; Phosphatidylcholines; Phosphatidylglycerols; Skin Absorption; Solvents; Time Factors; Tissue Distribution | 1998 |
Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood Proteins; Cholesterol, Dietary; Cholesterol, LDL; Drug Combinations; Female; Hypercholesterolemia; Kidney Diseases; Kidney Function Tests; Phosphatidylcholines; Phosphatidylglycerols; Protein Binding; Rabbits | 1998 |
ABELCET treatment.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Safety of high-dose amphotericin B lipid complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Infusions, Intravenous; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Binding of nystatin and amphotericin B with sterol-free L-dilauroylphosphatidylcholine bilayers resulting in the formation of dichroic lipid superstructures.
Topics: Amphotericin B; Circular Dichroism; Lipid Bilayers; Nystatin; Phosphatidylcholines; Spectrophotometry, Atomic | 1999 |
Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kidney; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Regression Analysis; Retrospective Studies | 1999 |
Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
Topics: Amphotericin B; Antifungal Agents; Centrifugation, Density Gradient; Cholesterol; Chromatography, High Pressure Liquid; Drug Combinations; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Phosphatidylcholines; Phosphatidylglycerols; Triglycerides | 1999 |
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Leukemia, Myeloid; Liver Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Splenic Diseases | 1999 |
Estimating the true cost of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Humans; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Leukemia; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.
Topics: Adult; Amphotericin B; Ascomycota; Bone Marrow Transplantation; Brain Abscess; Central Nervous System Fungal Infections; Craniotomy; Drug Combinations; Female; Graft vs Host Disease; Humans; Itraconazole; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Topics: Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Fluconazole; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic | 2000 |
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Topics: Amphotericin B; Antifungal Agents; Ascitic Fluid; Candidiasis; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Infant; Infusions, Intravenous; Male; Peritoneal Dialysis; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cricetinae; Dose-Response Relationship, Drug; Drug Combinations; Female; Leishmania donovani; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Macrophages; Mesocricetus; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Combinations; Endophthalmitis; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2000 |
A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fungi; Humans; Liposomes; Microbial Sensitivity Tests; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
[Role of the lipid formulation of amphotericin B in pediatric oncohematology].
Topics: Amphotericin B; Child; Drug Combinations; Humans; Immunosuppression Therapy; Leukemia; Mycoses; Myeloproliferative Disorders; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amphotericin B; Animals; Antifungal Agents; Cell Hypoxia; Ceramides; Cholesterol; Dose-Response Relationship, Drug; Drug Carriers; Drug Combinations; Humans; In Vitro Techniques; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Liposomes; Male; Mice; Mice, Inbred Strains; Nystatin; Oxidative Stress; Phosphatidylcholines; Phosphatidylglycerols; Phospholipids; Polyenes | 2000 |
Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation.
Topics: Adenocarcinoma; Aged; Amphotericin B; Anemia; Antifungal Agents; Colonic Neoplasms; Drug Combinations; Female; Fever; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Respiratory Distress Syndrome | 2000 |
Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Combinations; Female; Humans; Kidney; Male; Middle Aged; Mycoses; Organ Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Retrospective Studies; Survival Rate | 2000 |
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Female; Fluconazole; Humans; Liver Transplantation; Male; Medical Audit; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Care; Postoperative Complications; Prospective Studies | 2000 |
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Fluconazole; Immunocompromised Host; Male; Mice; Microbial Sensitivity Tests; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Successful treatment with liposomal amphotericin B of an intraabdomianl abscess due to Candida norvegensis associated with a Gore-Tex mesh infection.
Topics: Abdominal Abscess; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Combinations; Female; Humans; Phosphatidylcholines; Phosphatidylglycerols; Polytetrafluoroethylene; Surgical Mesh | 2000 |
Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biliary Tract; Biliary Tract Neoplasms; Candida; Candidiasis; Drug Combinations; Female; Humans; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex.
Topics: Adult; Amphotericin B; Anterior Chamber; Antifungal Agents; Drug Combinations; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Mycoses; Ophthalmic Solutions; Phosphatidylcholines; Phosphatidylglycerols; Visual Acuity | 2000 |
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lymphoma, Follicular; Male; Mucormycosis; Opportunistic Infections; Pancytopenia; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Amphotericin B lipid complex for neonatal invasive candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Drug Combinations; Humans; Infant; Infant, Newborn; Kidney Function Tests; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2001 |
Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol; Creatinine; Deoxycholic Acid; Drug Combinations; Hypercholesterolemia; Kidney; Kinetics; Lipoproteins; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Tissue Distribution | 2001 |
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Leukemia; Lung Transplantation; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2001 |
Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor.
Topics: Adjuvants, Pharmaceutic; Aged; Amphotericin B; Drug Combinations; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Treatment Outcome | 2001 |
Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Blastomycosis; Central Nervous System Fungal Infections; Cerebellar Diseases; Drug Combinations; Female; Humans; Itraconazole; Phosphatidylcholines; Phosphatidylglycerols; Recurrence | 2001 |
Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry, Physical; Emulsions; Excipients; Freeze Drying; Particle Size; Phosphatidylcholines; Rheology; Spectrophotometry, Ultraviolet; Viscosity | 2001 |
Mortality rates in comparative trials of formulations of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fever; Humans; Liposomes; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
Topics: Adult; Aerosols; Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Heart-Lung Transplantation; Humans; Incidence; Lung Diseases; Lung Transplantation; Middle Aged; Mycoses; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Period; Prospective Studies; Respiratory Mechanics; Safety; Survival Analysis | 2001 |
Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Phosphatidylcholines; Phosphatidylglycerols; Respiratory Distress Syndrome, Newborn; Treatment Outcome | 2001 |
Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Circular Dichroism; Dimerization; Ergosterol; Gels; Lipid Bilayers; Microscopy, Atomic Force; Models, Molecular; Molecular Structure; Phosphatidylcholines; Phospholipids; Solutions; Temperature | 2002 |
Palate ulcer due to mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Fatal Outcome; Humans; Male; Mucormycosis; Oral Ulcer; Palate, Hard; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Does amphotericin B lipid complex (Abelcet) affect haematological parameters erroneously?
Topics: Adult; Amphotericin B; Aspergillosis, Allergic Bronchopulmonary; Blood Cell Count; Burkitt Lymphoma; Diagnostic Errors; Drug Combinations; Erythrocyte Count; Female; Hematologic Tests; Hemoglobins; Humans; Male; Phosphatidylcholines; Phosphatidylglycerols; Platelet Count; Reproducibility of Results | 2001 |
Safety and efficacy of low-dose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antiviral Agents; Drug Combinations; Female; Fever; Hematologic Neoplasms; Humans; Hypokalemia; Kidney; Liver; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 2001 |
Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Female; Fusarium; Humans; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2002 |
Amphotericin B in oil-water lecithin-based microemulsions: formulation and toxicity evaluation.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Drug Stability; Emulsions; Injections, Intravenous; Lethal Dose 50; Male; Mice; Oils; Particle Size; Phosphatidylcholines; Rheology; Surface-Active Agents; Viscosity; Water | 2002 |
Lipid-based antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Lipids; Mycoses; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Topics: Abdominal Muscles; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Inflammatory Bowel Diseases; Itraconazole; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Pyoderma Gangrenosum; Rhizopus | 2002 |
Amphotericin B interactions with a DOPC monolayer. Electrochemical investigations.
Topics: Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Drug Combinations; Electrochemistry; In Vitro Techniques; Membrane Lipids; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
In vitro susceptibility of Leishmania infantum strains isolated from Spanish HIV-positive patients to Abelcet and Fungizone.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Drug Combinations; HIV Seropositivity; Humans; Leishmania infantum; Leishmaniasis, Visceral; Patients; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance; Fatal Outcome; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Humans; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Scedosporium; Statistics, Nonparametric | 2002 |
Infrequent occurrence of amphotericin B lipid complex-associated nephrotoxicity in various clinical settings at a university hospital: a retrospective study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Female; Hospitals, University; Humans; Kidney Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2002 |
Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Quality Control; Yeasts | 2002 |
Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.
Topics: Amphotericin B; Cholesterol; Electric Impedance; Electrochemistry; Ergosterol; Ion Channels; Lipid Bilayers; Macromolecular Substances; Membrane Potentials; Membranes, Artificial; Phosphatidylcholines; Sensitivity and Specificity; Spectrum Analysis; Sterols | 2002 |
Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Drug Compounding; Liposomes; Microscopy, Electron; Microscopy, Electron, Scanning; Particle Size; Phosphatidylcholines; Water | 2003 |
Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration.
Topics: Adolescent; Adult; Aged; Amphotericin B; Area Under Curve; Critical Illness; Drug Combinations; Female; Hemofiltration; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 2003 |
Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Calcium Carbonate; Candidiasis; Cellulitis; Child; Drug Carriers; Female; Headache; Humans; Hyperparathyroidism, Secondary; Immunocompromised Host; Itraconazole; Liposomes; Mucormycosis; Orbital Diseases; Parathyroid Hormone; Phosphates; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Seizures; Sinusitis; Vitamin D | 2003 |
Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
Topics: Amphotericin B; Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Deoxycholic Acid; Drug Combinations; Eye Diseases; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Retinal Diseases; Retinal Ganglion Cells; Vitreous Body | 2003 |
Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Cutaneous; Catheterization, Central Venous; Drug Combinations; Fungemia; Humans; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2002 |
Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chest Pain; Drug Combinations; Dyspnea; Female; Flushing; Humans; Hypoxia; Liposomes; Male; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2003 |
Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Chi-Square Distribution; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Mediterranean Region; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cholesterol; Chromatography, High Pressure Liquid; Female; Liposomes; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Tuftsin | 2003 |
Amphotericin B channels in the bacterial membrane: role of sterol and temperature.
Topics: Amphotericin B; Cell Membrane Permeability; Dimyristoylphosphatidylcholine; Drug Resistance, Bacterial; Escherichia coli; Ion Channel Gating; Ion Channels; Lipid Bilayers; Liposomes; Membranes, Artificial; Phosphatidylcholines; Sterols; Temperature | 2003 |
Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Combinations; Female; Humans; Liver Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2003 |
Membrane permeabilizing activity of amphotericin B is affected by chain length of phosphatidylcholine added as minor constituent.
Topics: Acylation; Amphotericin B; Ion Channels; Liposomes; Macromolecular Substances; Membrane Fluidity; Membrane Lipids; Membranes, Artificial; Molecular Conformation; Permeability; Phosphatidylcholines; Solutions; Structure-Activity Relationship | 2003 |
Polyene and cytokine treatment of experimental aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Immunocompromised Host; Immunosuppressive Agents; Kidney; Lung; Mice; Mice, Inbred ICR; Nystatin; Phosphatidylcholines; Phosphatidylglycerols; Survival Analysis | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Study of the toxicity of a new lipid complex formulation of amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Body Weight; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Combinations; Erythrocytes; Female; In Vitro Techniques; Kidney; Lethal Dose 50; Liver; Macrophages, Peritoneal; Mice; Organ Size; Phosphatidylcholines; Phosphatidylglycerols; Toxicity Tests | 2004 |
Reversible dilated cardiomyopathy related to amphotericin B therapy.
Topics: Adult; Amphotericin B; Antifungal Agents; Cardiomyopathy, Dilated; Coccidioidomycosis; Drug Combinations; Echocardiography; Humans; Injections, Intravenous; Male; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Visceral leishmaniasis treatment, Italy.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Combinations; Drug Therapy; Humans; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Fat Emulsions, Intravenous; Female; Immunocompromised Host; Immunosuppressive Agents; Mice; Mice, Inbred ICR; Nystatin; Phosphatidylcholines; Phosphatidylglycerols; Polyenes | 2004 |
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 2004 |
Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
Topics: Amphotericin B; Animals; Candidiasis; Chemistry, Pharmaceutical; Deoxycholic Acid; Emulsions; Freeze Drying; Immunocompetence; Male; Mice; Neutropenia; Phosphatidylcholines | 2004 |
Effect on amphotericin B lipid complex use of a clinical decision support system for computerized prescriber order entry.
Topics: Amphotericin B; Antifungal Agents; Data Collection; Decision Making; Decision Making, Organizational; Drug Combinations; Drug Prescriptions; Hospitals, University; Humans; Medical Records Systems, Computerized; Pharmacists; Phosphatidylcholines; Phosphatidylglycerols; Physicians; Practice Patterns, Physicians' | 2004 |
Modification of prostanoid secretion in endothelial cells by amphotericin B acting synergistically with interleukin-1beta: possible explanation of proinflammatory effects.
Topics: Amphotericin B; Cell Line; Cells, Cultured; Drug Combinations; Drug Synergism; Endothelial Cells; Humans; Interleukin-1; Liposomes; Macrophages; Phosphatidylcholines; Phosphatidylglycerols; Prostaglandins; Recombinant Proteins; Umbilical Veins | 2004 |
Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Discitis; Drug Administration Schedule; Drug Combinations; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteomyelitis; Phosphatidylcholines; Phosphatidylglycerols; Thoracic Vertebrae | 2004 |
Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antiprotozoal Agents; Drug Combinations; Humans; Immunocompromised Host; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
An amphotericin B-fluorescein conjugate as a powerful probe for biochemical studies of the membrane.
Topics: Amines; Amphotericin B; Antifungal Agents; Cell Membrane; Electrolytes; Fluorescein; Fungi; Humans; Immunoglobulin G; Indicators and Reagents; Jurkat Cells; Microscopy, Fluorescence; Molecular Probes; Phosphatidylcholines; Piperazines; Saccharomyces cerevisiae | 2004 |
Fatal fat embolism following amphotericin B lipid complex injection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brain; Cryptococcus neoformans; Drug Combinations; Drug Delivery Systems; Drug Therapy, Combination; Embolism, Fat; Fat Emulsions, Intravenous; Fatal Outcome; Humans; Injections, Intravenous; Male; Meninges; Meningitis, Cryptococcal; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
[Role of Abelcet in children with febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Child; Creatinine; Drug Combinations; Fever; Hematologic Neoplasms; Humans; Kidney Function Tests; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2004 |
Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Calcineurin Inhibitors; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Infant; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Registries; Retrospective Studies; Vancomycin | 2004 |
Unidirectional inhibition of lipid transfer protein I-mediated transfer of cholesteryl esters between high-density and low-density lipoproteins by amphotericin B lipid complex.
Topics: Amphotericin B; Analysis of Variance; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Drug Combinations; Glycoproteins; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Drug Combinations; Echinocandins; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mucormycosis; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Survival | 2005 |
Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Child, Preschool; Drug Combinations; Drug Interactions; Female; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Mycoses; Organ Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies | 2005 |
Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Topics: Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 2004 |
Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Registries | 2005 |
Treatment of Candida infections with amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome | 2005 |
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Combinations; Female; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome | 2005 |
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis | 2005 |
Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Combinations; Female; Humans; Immunocompromised Host; Male; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome | 2005 |
Study of renal safety in amphotericin B lipid complex-treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kidney Diseases; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Registries; Risk | 2005 |
Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2005 |
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Combinations; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2005 |
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Case-Control Studies; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Child; Child, Preschool; Databases, Factual; Drug Combinations; Drug Evaluation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2005 |
Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.
Topics: Adult; Amphotericin B; Antifungal Agents; Debridement; Drug Combinations; Humans; Male; Mucorales; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Wounds, Penetrating | 2005 |
The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Treatment Outcome | 2005 |
Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Cells, Cultured; Deoxycholic Acid; Drug Combinations; Female; Fusarium; Humans; Macrophages, Alveolar; Phosphatidylcholines; Phosphatidylglycerols; Rabbits | 2006 |
Nosocomial pulmonary Rhizopus diagnosed by bronchoalveolar lavage with cytology in a child with acute lymphoblastic leukemia.
Topics: Amphotericin B; Bronchoalveolar Lavage; Child; Cross Infection; Drug Combinations; Female; Humans; Lung Diseases, Parasitic; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhizopus; Tobramycin | 2006 |
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcium; Colony Count, Microbial; Confidence Intervals; Creatinine; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edetic Acid; Lung Diseases, Fungal; Male; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Survival Analysis; Time Factors | 2006 |
Binding of antibiotic amphotericin B to lipid membranes: a 1H NMR study.
Topics: Amphotericin B; Animals; Chickens; Ergosterol; Hydrophobic and Hydrophilic Interactions; Lipids; Liposomes; Magnetic Resonance Spectroscopy; Molecular Structure; Phosphatidylcholines; Protons; Solutions; Static Electricity | 2006 |
Antifungals and renal safety--getting the balance right.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Kidney; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
The experience is CLEAR.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis | 2006 |
Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations.
Topics: Amphotericin B; Antibodies; Antifungal Agents; Chemistry, Pharmaceutical; Drug Combinations; Humans; In Vitro Techniques; Lipids; Lipoproteins, HDL; Phosphatidylcholines; Phosphatidylglycerols; Phospholipid Transfer Proteins; Protein Binding | 2006 |
Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Topics: Administration, Inhalation; Aerosols; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blood Urea Nitrogen; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Kidney Tubules; Liposomes; Lung Diseases, Fungal; Mice; Mice, Inbred DBA; Phosphatidylcholines; Phosphatidylglycerols; Survival Analysis; Time Factors | 2006 |
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Membrane interaction of amphotericin B as single-length assembly examined by solid state NMR for uniformly 13C-enriched agent.
Topics: Amphotericin B; Antifungal Agents; Carbon Isotopes; Indicators and Reagents; Magnetic Resonance Spectroscopy; Membranes, Artificial; Phosphatidylcholines; Streptomyces | 2006 |
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Drug Combinations; Injections, Intravenous; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Time Factors | 2006 |
Amphotericin B-associated hyperbilirubinemia: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Carcinoma, Non-Small-Cell Lung; Deoxycholic Acid; Drug Combinations; Female; Humans; Hyperbilirubinemia; Liver; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Comparison of antifungal treatments for murine fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Drug Combinations; Echinocandins; Fusarium; Kidney; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mycoses; Neutropenia; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Mycograb for the treatment of invasive candidiasis.
Topics: Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Candidiasis; Drug Combinations; HSP90 Heat-Shock Proteins; Humans; Phosphatidylcholines; Phosphatidylglycerols; Recombinant Proteins; Research Design; Survival Analysis | 2006 |
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Female; Leukocytes, Mononuclear; Liposomes; Lung; Macrophages, Alveolar; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Tissue Distribution | 2006 |
Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.
Topics: Aerosols; Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Lung; Lung Transplantation; Metabolic Clearance Rate; Nebulizers and Vaporizers; Phosphatidylcholines; Phosphatidylglycerols; Radiography; Radioisotopes; Technetium | 2006 |
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Echinocandins; Galactose; Injections, Intravenous; Lipopeptides; Male; Mannans; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2007 |
Ileal perforation and reactive hemophagocytic syndrome in a patient with disseminated histoplasmosis: the role of the real-time polymerase chain reaction in the diagnosis and successful treatment with amphotericin B lipid complex.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Combinations; Histoplasma; Histoplasmosis; HIV Infections; HIV-1; Humans; Ileum; Intestinal Perforation; Lymphohistiocytosis, Hemophagocytic; Male; Phosphatidylcholines; Phosphatidylglycerols; Puerto Rico; Treatment Outcome | 2007 |
Development of candidemia on caspofungin therapy: a case report.
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Catheters, Indwelling; Cross Infection; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Lipopeptides; Male; Pancreaticoduodenectomy; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications | 2006 |
Outcomes of invasive zygomycosis infections in renal transplant recipients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Transplantation; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Risk Factors; Zygomycosis | 2007 |
A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B.
Topics: Amides; Amination; Amphotericin B; Antifungal Agents; Biotin; Liposomes; Phosphatidylcholines; Potassium; Potentiometry | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.
Topics: Amphotericin B; Antifungal Agents; Cyanosis; Deoxycholic Acid; Drug Combinations; Fingers; Hand; Humans; Male; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols | 2007 |
Effect of antibiotic amphotericin B on structural and dynamic properties of lipid membranes formed with egg yolk phosphatidylcholine.
Topics: Amphotericin B; Anti-Bacterial Agents; Egg Yolk; Electrons; Molecular Structure; Phosphatidylcholines; Spectrophotometry; X-Ray Diffraction | 2007 |
CNS blastomycosis in a young man working in fields after Hurricane Katrina.
Topics: Adult; Agricultural Workers' Diseases; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Brain; Cognition Disorders; Contrast Media; Deoxycholic Acid; Disasters; Drug Combinations; Encephalitis; Facial Dermatoses; Gadolinium; Humans; Itraconazole; Louisiana; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Phosphatidylcholines; Phosphatidylglycerols; Skin Ulcer | 2007 |
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Female; Fluconazole; Fungemia; Humans; Ileostomy; Lipopeptides; Middle Aged; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Practice Guidelines as Topic | 2007 |
Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Lung Diseases, Fungal; Mitochondrial Diseases; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Syndrome; Transplantation, Homologous | 2007 |
Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in a one-year old child.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Combinations; Humans; Immunocompromised Host; Infant; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 2007 |
Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis; Cryptococcosis; Drug Combinations; Fungemia; Humans; Phosphatidylcholines; Phosphatidylglycerols; Viscera | 2007 |
Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Arteritis; Body Temperature; Brain; Cisterna Magna; Coccidioides; Drug Combinations; Fluconazole; Granuloma; Injections, Intravenous; Male; Meningitis, Fungal; Phosphatidylcholines; Phosphatidylglycerols; Rabbits; Spinal Cord; Survival Analysis | 2007 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Autopsy; Chemical and Drug Induced Liver Injury; Drug Carriers; Drug Combinations; Female; Hematologic Neoplasms; Humans; Liposomes; Liver; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2007 |
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole | 2008 |
Liposomal amphotericin B associated with severe hyperphosphatemia.
Topics: Adolescent; Amphotericin B; Child; Drug Combinations; Female; Humans; Hyperphosphatemia; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Renal Insufficiency | 2008 |
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Combinations; Female; Hematologic Neoplasms; Humans; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Risk Factors; Salvage Therapy; Treatment Outcome | 2008 |
Comparison of lipid amphotericin B preparations in treating murine zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Diabetic Ketoacidosis; Disease Models, Animal; Drug Combinations; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Treatment Outcome; Zygomycosis | 2008 |
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Hyphae; Liposomes; Microbial Sensitivity Tests; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Topics: Adult; Amphotericin B; Aspergillus fumigatus; Drug Combinations; Fusarium; Humans; Hyphae; Immunologic Factors; Monocytes; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Reactive Oxygen Species; Respiratory Burst; Tetrazolium Salts | 2008 |
Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance.
Topics: Amphotericin B; Cholesterol; Ergosterol; Liposomes; Models, Biological; Molecular Structure; Phosphatidylcholines; Sterols; Surface Plasmon Resonance | 2008 |
Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
Topics: Amphotericin B; Caprylates; Drug Delivery Systems; Emulsions; Glycine max; Lecithins; Light; Molecular Conformation; Oils; Particle Size; Phosphates; Phosphatidylcholines; Polyethylene Glycols; Polysorbates; Scattering, Radiation; Surface Properties; Surface-Active Agents; Water | 2008 |
Ergosterol increases the intermolecular distance of amphotericin B in the membrane-bound assembly as evidenced by solid-state NMR.
Topics: Amphotericin B; Biophysical Phenomena; Cholesterol; Ergosterol; Ion Channels; Lipid Bilayers; Magnetic Resonance Spectroscopy; Models, Chemical; Models, Molecular; Molecular Conformation; Phosphatidylcholines; Protein Binding; Spectrophotometry, Ultraviolet; Streptomyces; Ultraviolet Rays | 2008 |
Amphotericin B-induced ion flux is markedly attenuated in phosphatidylglycerol membrane as evidenced by a newly devised fluorometric method.
Topics: Amphotericin B; Antifungal Agents; Fluorescent Dyes; Fluorometry; Ion Transport; Liposomes; Permeability; Phosphatidylcholines; Phosphatidylglycerols | 2009 |
Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane.
Topics: Amphotericin B; Antifungal Agents; Biological Transport; Cell Membrane; Cell Wall; Chemistry, Pharmaceutical; Cholesterol; Diffusion; Ergosterol; Fluorescence Recovery After Photobleaching; Membrane Fluidity; Microscopy, Confocal; Phosphatidylcholines; Saccharomyces cerevisiae; Temperature; Time Factors | 2010 |
Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Cell Culture Techniques; Cell Line; Erythrocytes; Female; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Phosphatidylcholines; Rabbits; Stigmasterol | 2011 |
Small-angle neutron scattering studies of the effects of amphotericin B on phospholipid and phospholipid-sterol membrane structure.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Cholesterol; Ergosterol; Humans; Kinetics; Lipid Bilayers; Models, Molecular; Molecular Structure; Mycoses; Neutron Diffraction; Phosphatidylcholines; Phospholipids; Scattering, Small Angle; Sterols; Temperature | 2011 |
Head-to-tail interaction between amphotericin B and ergosterol occurs in hydrated phospholipid membrane.
Topics: Amphotericin B; Antifungal Agents; Carbon Isotopes; Cell Membrane; Deuterium Exchange Measurement; Ergosterol; Lipid Bilayers; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Phosphatidylcholines; Phospholipids; Phosphorus Isotopes; Saccharomyces cerevisiae; Water | 2012 |
Probing amphotericin B single channel activity by membrane dipole modifiers.
Topics: Amphotericin B; Androstanols; Cholesterol; Ergosterol; Ketocholesterols; Membranes, Artificial; Phosphatidylcholines; Pyridinium Compounds; Quercetin; Styrenes | 2012 |
Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association.
Topics: Amphotericin B; Cholesterol; Drug Carriers; Emulsions; Microscopy; Nanostructures; Oleic Acid; Particle Size; Phosphatidylcholines; Polysorbates; Rheology; Surface-Active Agents | 2012 |
Box C/D small nucleolar RNA (snoRNA) U60 regulates intracellular cholesterol trafficking.
Topics: Amphotericin B; Animals; Base Sequence; Biological Transport; Cell Membrane; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Endoplasmic Reticulum; Gene Expression Regulation; Gene Knockdown Techniques; Genetic Loci; Haploinsufficiency; Humans; Intracellular Space; Mice; Molecular Sequence Data; Mutation; Phosphatidylcholines; Rats; Ribonucleoproteins, Small Nucleolar; RNA, Small Nucleolar | 2013 |
Interaction of amphotericin B with lipid monolayers.
Topics: Amphotericin B; Ergosterol; Phosphatidylcholines | 2014 |
Study of amphotericin B magnetic liposomes for brain targeting.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Carotid Arteries; Cholesterol; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Injections, Intravenous; Liposomes; Magnetic Phenomena; Magnetite Nanoparticles; Neurons; Particle Size; Phosphatidylcholines; Rats, Sprague-Dawley; Tissue Distribution; Up-Regulation | 2014 |
Neutron Scattering Studies of the Effects of Formulating Amphotericin B with Cholesteryl Sulfate on the Drug's Interactions with Phospholipid and Phospholipid-Sterol Membranes.
Topics: Amphotericin B; Cholesterol Esters; Membranes, Artificial; Phosphatidylcholines; Phospholipids | 2015 |
A Cheap and Convenient Method of Liposome Preparation Using Glass Beads as a Source of Shear Force.
Topics: Amphotericin B; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Cost-Benefit Analysis; Glass; Liposomes; Particle Size; Phosphatidylcholines; Shear Strength | 2017 |
Electrical resonance of Amphotericin B channel activity in lipidic membranes.
Topics: Amphotericin B; Electricity; Lipid Bilayers; Phosphatidylcholines; Time Factors | 2017 |
Pore-forming activity of new conjugate antibiotics based on amphotericin B.
Topics: Amphotericin B; Anti-Bacterial Agents; Fluoresceins; Lipid Bilayers; Microscopy, Fluorescence; Phosphatidylcholines | 2017 |
Effect of Anti-Leishmania Drugs on the Structural and Elastic Properties of Ultradeformable Lipid Membranes.
Topics: Amphotericin B; Antiprotozoal Agents; Imiquimod; Indoles; Liposomes; Phosphatidylcholines; Phosphorylcholine; Sodium Cholate; X-Ray Diffraction | 2018 |
Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Antifungal Agents; Cholesterol; Molecular Dynamics Simulation; Phosphatidylcholines | 2018 |
Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation.
Topics: Amphotericin B; Cholesterol; Excipients; Nanoparticles; Particle Size; Phosphatidylcholines; Phosphatidylglycerols | 2019 |
Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Topics: Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Compressive Strength; Disease Models, Animal; Dosage Forms; Drug Compounding; Drug Delivery Systems; Eye Infections, Fungal; Humans; Keratitis; Male; Miniaturization; Needles; Permeability; Phosphatidylcholines; Polyvinyl Alcohol; Povidone; Rabbits | 2019 |
Placental Trophoblast-Inspired Lipid Bilayers for Cell-Free Investigation of Molecular Interactions.
Topics: Amphotericin B; Diethylhexyl Phthalate; Female; Humans; Lipid Bilayers; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Placenta; Plasticizers; Pregnancy; Quartz Crystal Microbalance Techniques; Sphingomyelins; Trophoblasts | 2020 |
Scalable solvent-free production of liposomes.
Topics: Amphotericin B; Chemistry, Pharmaceutical; Doxorubicin; Liposomes; Phosphatidylcholines; Solvents | 2020 |
Influence of amphotericin B on the DPPC/DOPC/sterols mixed monolayer in the presence of calcium ions.
Topics: Amphotericin B; Calcium; Humans; Ions; Phosphatidylcholines; Sterols | 2021 |
Mycobacterium abscessus cell wall and plasma membrane characterization by EPR spectroscopy and effects of amphotericin B, miltefosine and nerolidol.
Topics: Amphotericin B; Anti-Bacterial Agents; Cell Membrane; Cell Wall; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium abscessus; Phosphatidylcholines; Phosphorylcholine; Sesquiterpenes; Spin Labels; Stearic Acids | 2022 |